AWGL relocation to Canolfan Iechyd Genomig Cymru - Wales Genomic Health Centre
Four teams from Cardiff and Vale University Health Board have been recognised for their outstanding achievements in cancer services at the Moondance Cancer Awards. 
Notification of potential delay in processing genetic test results.
                AWMGS helping out with the collection at the Wales V France Six Nations clash on Sunday, raising funds for the Maxwell Family Fund.
Testing of BRCA1 and BRCA2 now available to guide treatment options for prostate cancer patients
Notification of a voluntary resignation from UKAS ISO15189 accreditation by the All Wales Genomics Laboratory (AWGL)
  QuicDNA project triumphs at MediWales Innovation Awards 2023
  Canolfan Iechyd Genomig Cymru (CIGC) in Coryton, North Cardiff officially opened its doors on 7th December, to serve as a cornerstone of Wales’ precision health ambition.
  QuicDNA and its partners have triumphed at the Advancing Healthcare Awards Wales 2023, winning two awards for its transformative impact on healthcare in Wales and its potential for roll-out across the nation.
  All Wales Medical Genomics Service Clinical Genetics Services Relocating to Cardiff Edge Life Science Park: A New Era for Genomic Medicine in Wales 
 August 22nd 2023 AWMGS raise the profile of the QuicDNA Clinical Trial as Wales play South Africa     
24 July 2023 Lung Cancer Patient begins fundraising cycle from Cardiff to Paris to improve diagnosis for others
 25 April 2023 Minister for Health and Social Services Eluned Morgan MS visited the Institute of Medical Genetics at University Hospital of Wales to learn more about the launch of the ‘QuicDNA’ clinical trial. 
Festival of Genomics & Biodata 2023
  Launch of the Angioimmunoblastic T-cell lymphoma (AITCL) testing service
  Advances Wales magazine marks centennial issue with a special feature on 'Innovation in medical genomics and genetics'
  AWMGS is pleased to announce the availability of PIK3CA genetic screening for Welsh patients with particular types of secondary breast cancer.
  Update on the phased implementation of myeloid malignancy and chronic lymphocytic leukaemia to the Trusight Oncology 500
AWMGS is delighted to announce the availability of POLE NGS Testing across NHS Wales.
Congratulations to all of our staff who recently featured at this year's ACGS conference; the 'largest of the constituent groups of the British Society for Genetic Medicine'.  
  Celebrations as the winners of the Moondance Cancer Awards 2022 are announced  
  All Wales Psychiatric Genomics Service Officially Launches in Wales
    BBC News Special - Wales Infants and Children's Genome Service
  AWMGS Secures Additional NovaSeq 6000
  AWMGS honoured at the Healthcare Science Cymru Conference 2022
  Awards fever continues as AWMGS receives MediWales Innovation Award
  AWMGS wins big at the 2021 Advancing Healthcare Awards
    AWMGS is pleased to announce the official public launch of the Cymru Service for Genomic Oncology DIagnoses, (CYSGODI)
  Bon Voyage Prof Sampson!
  AWMGS scoops Innovation award at the Healthcare Science Awards
  Wales Infants and childreN’s Genome Service (WINGS) shortlisted for Advancing Healthcare Award (AHA)  
  ARX Associated Disorders Targeted Testing Services Update - March 2021
  Are you considering a career in genomics and would like to be part of our expanding service?
  Remembering the life and work of Professor Peter Harper
Roll out of Phase 3 NTRK gene fusion testing
   Huntington's Disease Service Update
  Applications are inivited for ST3 Training Post in Clinical Genetics.
  The All Wales Medical Genomics Service is thrilled to announce the availability of DPYD screening for cancer patients in Wales who are being treated with certain types of chemotherapy.
  NEW PHASE 2 SERVICE LAUNCH: Phased introduction of NTRK gene fusion testing for patients with solid tumours in Wales
NEW SERVICE LAUNCH: RNA-based Next Generation Sequencing service for solid tumours
  Change in JAK2 Exon 12 and MPL Testing Provision by AWMGS   From 20/04/2020 the All Wales Genomic Laboratory will be providing JAK2 exon 12 and MPL testing service using the Illumina Myeloid panel. These tests will no longer be sent to Bristol for testing.
The All Wales Medical Genomics Service (AWMGS) attended the 14th Annual MediWales Awards ceremony on December 4th at the National Museum of Wales, an opportunity for over '300 VIP guests to celebrate the achievements of the NHS, Life Sciences and Health Technology Communities'.
We are pleased to announce that the All Wales Genetics Laboratory will now be providing ROS1 FISH analysis for Welsh patients with NSCLC.
  The Head of Laboratory at the All Wales Medical Genomics Service would like to thank all the speakers and attendees for a successful Precision Medicine Cancer Diagnosis Networking Event.